Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science

Similar documents
The Prescription Drug Overdose Epidemic

Opioids drive continued increase in drug overdose deaths

CDC s Efforts to End the Opioid Epidemic

Article #2 Prescription Drug Overdose CDC: Centers for Disease Control and Prevention. Understanding the Epidemic

Oregon s PDMP: An epidemiological assist tool

Understanding the Opioid Crisis: What s at the Heart of the Matter?

CDC s Approach to Addressing the Opioid Overdose Epidemic

Prescription Drug Monitoring Programs and Other State-Level Strategies

Opioid Use and Other Trends

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD

OPIOID OVERDOSE EPIDEMIC: What Healthcare Providers Need to Know

Barbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County

Mingo County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Putnam County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Greenbrier County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Pocahontas County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Kanawha County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

ACCG Mental Health Summit

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM

Prescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017

Prescription Drugs: Issues in Treatment, Supervision and Case Management

Pennsylvania Prescription Drug Monitoring Program Trends,

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

Opioid Overdose in Oregon Report to the Legislature

Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference?

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Using PDMP Data to Guide Interventions with Possible At-Risk Prescribers

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

Prescription Drug Monitoring Program (PDMP) Delaware. Information contained in this presentation is accurate as of November 2017

The Epidemiology of Opioid Abuse. Thomas Dobbs, MD, MPH Mississippi State Department of Health

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

Prescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort

Prescription Opioid Overdose in Oregon: A public health perspective

Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States

Thyroid cancer in the United States: Recent increases

Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Addressing the Opioid Epidemic in Tennessee

Arkansas Prescription Monitoring Program

Community Epidemiology Report November 2014

Top 10 narcotic pain pills

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

COLORADO PRESCRIPTION DRUG MONITORING PROGRAM

Florida s Roadmap to End its Prescription Drug Abuse Epidemic Florida Attorney General Pam Bondi One Page Summary

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

Shawn A. Ryan, MD, MBA Assistant Professor, Dept. of Emergency Medicine, University of Cincinnati Chair of Quality & Patient Safety, Jewish

4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP

How many days does hydrocodone stay in your system

Protecting Children s Safety: How Prescription Drug Monitoring Programs Can Assist An Update Presenter: John L. Eadie Moderator: Cindy Rodgers

ASTHO President s Challenge 15 x 15: Reduce Prescription Drug

High-Decile Prescribers: All Gain, No Pain?

Emergency Department Visits Involving Nonmedical Use of Selected Prescription Drugs --- United States,

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Arkansas Department of Health

Michael M. Miller, MD, FASAM, FAPA

Addressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust

5/16/2016. Roadmap. Legal Competencies. Prescription Drug Overdose at Epidemic Levels

The State of Asthma. Jeanne Moorman, NCEH Survey Statistician National Asthma Program

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative

Drug Overdose Deaths St. Louis County, Missouri

Drug poisonings in Southern Nevada,

VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC

Shannon Whitman Program Administrator Advancing Use of the MN PMP

OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS

Strategies to Manage The Opioid Crisis

ANNUAL REPORT

Lisa Marzilli, PharmD, CDOE TOP 3 REASONS PEOPLE VISIT THEIR DOCTOR

COUNTY OF SAN DIEGO. Opioid Update

Overdose deaths from prescription opioids in the U.S. quadrupled from 1999

The Opioid Epidemic: HHS Response

using analytics to identify and strategically manage patient opioid abuse

Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services

Prescription Monitoring Program Center of Excellence at Brandeis. Drug-Related Deaths in Virginia: Medical Examiner Use of PMP Data

Prescribing Opioids in the Opioid Epidemic. Scott Woffinden, PA-C Jason Chapman, JD

Online Appendix. Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 2017 (2017Q4)

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

Mortality Slide Series. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention

Figure 1. Fentanyl-Related Drug Overdoses, Ohio,

Workforce Drug Positivity at Highest Rate in a Decade, Finds Analysis of More Than 10 Million Drug Test Results

Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

PRESCRIBING GUIDELINES

Opioid Deaths Quadruple Since 1999

REB CLOSE, MD Community Hospital of the Monterey Peninsula

Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield and

2018 Annual Meeting & Educational Conference Opioids In Workers Compensation: Research From WCRI

Opioid Initiative Wave I PDMPs and Screening

Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx

PDMP Tools to Identify Red Flag Situations

Prescription Drug Abuse National Perspective

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2017 (2017Q3)

Responding to the Opioid Addiction Epidemic

Transcription:

Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science National Center for Injury Prevention and Control Division of Analysis, Research, and Practice Integration

cdc.gov/vitalsigns

Prescription painkiller overdoses are a serious problem among women About 18 women died every day in 2010 of a prescription painkiller overdose. For every woman who dies of a prescription painkiller overdose, 30 go to the emergency department for painkiller misuse or abuse. Women ages 45 to 54 are at the highest risk of dying of a prescription painkiller overdose. Non-Hispanic white and American Indian or Alaska Native women have the highest risk of prescription painkiller overdose death.

Prescription opioid painkiller deaths are a growing problem among women

Key Findings In 2010, drug overdoses in the United States caused 15,323 deaths among women. Opioid pain relievers prescription painkillers were involved in 6,631 deaths. Deaths from prescription painkiller overdoses among women have increased more than 400% since 1999, compared to 265% among men

Vital Signs: Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines United States, 2012

National Vital Statistics System Drug overdose death rate by state, 1999-2010

259

Prescriptions per 100 people, 2012

Prescriptions per 100 people, 2012

Opioid prescribing can vary 3-fold between states Number of painkiller prescriptions per 100 people 52 71 HI 72 82.1 82.2 95 96 143

Regional Patterns in Prescribing, 2012 South highest OPR and benzodiazepines Alabama highest OPR West Virginia highest benzodiazepines Northeast highest rates for long-acting/extended-release OPR and high-dose OPR Maine highest for long-acting OPR Delaware highest for high-dose OPR Adjacent states vary widely New York 2/3 of OPR and benzodiazepine rates of Pennsylvania Illinois 60% of the OPR rate in Indiana

Reasons for Interstate Prescribing Variation State prevalence of painful conditions Northeast oldest, 14.1% aged 65+ years; Midwest second, 13.5% Poverty rates South highest rates of poverty Proportion of minorities Minorities represent larger proportion in south and west Prescribing rates lower among minorities Other reasons for variation Prescriber norms Rates of misuse and abuse State policies

Key Findings In 2011, opioid pain relievers (OPR) caused 16,917 overdose deaths in the United States Benzodiazepine sedatives were involved in 31% of those deaths Use of these drugs varied greatly among states in 2012 Highest prescribing rates were found in the southern region

Decline in Drug Overdose Deaths After State Policy Changes Florida, 2010 2012

Florida and the Epidemic 2003-2009 84% increase in prescription drug overdoses 264% increase in oxycodone overdoses In 2009, 8 people died of overdoses every day 2010: 90 of the top 100 oxycodone purchasing physicians in US were in Florida 900+ pain clinics

The Problem of Pill Mills You just walk in, they ask you what hurts, they take your blood pressure, they weigh you, and they say actually literally sometimes, What do you want? How many do you take a day? You could be ridiculous and say 40. I mean, I could get 200 of each, Roxi's and Oxy's at the same time, which makes no sense, and Xanny bars (Xanax) at the same time. They just ask you what you want. White female, 41 Rigg KK, March SJ, Inciardi JA. Prescription drug abuse and diversion: role of the pain clinic. J Drug Issues. 2010 ; 40(3): 681 702.

16 Florida opioid overdoses fell sharply between 2010 and 2012 14 Opioid pain reliever overdoses 12 10 8 Oxycodone overdoses 6 4 Benzodiazepine overdoses 2 0 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Johnson H; Paulozzi L; Porucznik C. Mack K. Herter B. Decline in Drug Overdose Deaths After State Policy Changes Florida, 2010 2012. MMWR. 63(26). 569-74. July 2014.

Florida s Policy Response Jan. 2010: State legislature required pain clinics register with the state Feb. 2010: DEA and various Florida law enforcement agencies began to work together in Operation Pill Nation Late 2010: Pain clinic regulations further expanded Feb. 2011: Law enforcement conducted statewide raids July 2011: State legislature prohibited physician dispensing of schedule II or III; activated regional strike forces to address the emergency. Sept. 2011: Mandatory dispenser reporting to the newly established PDMP 2012: State legislature expanded regulation of wholesale drug distributors

Drug overdose death rates and selected prescription drug diversion and misuse actions taken Florida, 2006 2012 4.5 A B C D E F G 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 Oxycodone Alprazolam Methadone Morphine Hydrocodone Heroin 0.0 Jan Jun Jul Dec Jan Jun Jul Dec Jan Jun Jul Dec Jan Jun Jul Dec Jan Jun Jul Dec Jan Jun Jul Dec Jan Jun Jul Dec 2006 2007 2008 2009 2010 2011 2012 A. January 4, 2010. Pain clinics must register. B. February, 2010. Operation Pill Nation: DEA, state and local law enforcement begin investigation of unscrupulous pain clinics. C. October 1, 2010. Pain clinic regulation expanded. D. February 23, 2011. Operation Pill Nation: joint law enforcement raids begin. E. July 1, 2011. Physician dispensing prohibited and statewide regional strike forces activated. F. September 1, 2011. Mandatory reporting to prescription drug monitoring program begins. G. July 1, 2012. Wholesale distributor regulations expanded.

To Work with Providers, States Can Take steps to improve prescription drug monitoring programs Consider setting up programs for Medicaid, workers compensation programs, and state-run health plans that identify and address improper patient use of painkillers Make it easier for prescribers to use PDMPs by providing them unsolicited reports and making data available in real-time

To Reverse this Epidemic, States Can Consider Pill mill, doctor shopping, and other laws that can reduce prescription painkiller abuse Universal prescriber use of PDMPs when prescribing controlled substances Enhanced coverage for non-drug treatments for chronic pain Increased access to substance abuse treatment (including immediate access to treatment for pregnant women)

http://www.phconnect.org/group/pdo http://www.cdc.gov/injury/socialmedia

For more information, please contact the Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA 30333 Telephone: 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348 E-mail: cdcinfo@cdc.gov Web: www.cdc.gov/injury The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The presenter has no conflicts of interest to report. National Center for Injury Prevention and Control Division of Analysis, Research, and Practice Integration